Term
|
Definition
CH 7 Cholinoceptor-Activating & Cholinesterase-Inhibiting Drugs
Direct-Acting Choline Esters
Activates M receptors on effector cells to alter organ function and on nerve terminals to inhibit the release of their neurotransmitter
|
|
No clinical use because it is hydrolyzed by cholinesterase in seconds
|
|
|
|
Term
|
Definition
CH 7 Cholinoceptor-Activating & Cholinesterase-Inhibiting Drugs
Direct-Acting Choline Esters
Nonselective M and N agonist; more resistant to cholinesterase
|
Bronchospasm
|
Glaucoma - used topically to reduce intraocular pressure
|
|
|
|
Term
|
Definition
CH 7 Cholinoceptor-Activating & Cholinesterase-Inhibiting Drugs
Direct-Acting Choline Esters
Selective muscarinic agonist, negligible effect on nicotinic; not hydrolyzed by cholinesterase
|
Bronchospasm in asthmatics
|
Urinary retention or ileus - stimulates bladder contraction and GI motility
|
|
|
|
Term
|
Definition
CH 7 Cholinoceptor-Activating & Cholinesterase-Inhibiting Drugs
Direct-Acting Muscarinic Alkaloids or Synthetics
Muscarinic agonist (like Bethanechol)
|
Bronchospasm, bradychardia, excessive sweating/salivation
|
Glaucoma; Sjogren’s syndrome (autoimmune disease that destroys glands producing tears and saliva)
|
|
|
|
Term
|
Definition
CH 7 Cholinoceptor-Activating & Cholinesterase-Inhibiting Drugs
Direct-Acting Muscarinic Alkaloids or Synthetics
Synthetic M3-selective (similar to Pilocarpine)
|
|
Sjogren’s syndrome
|
|
|
|
Term
|
Definition
CH 7 Cholinoceptor-Activating & Cholinesterase-Inhibiting Drugs
Direct-Acting Nicotinic Agonist
NN and NM receptor agonist
|
Increased GI activity and BP, high doses cause seizures
|
Smoking cessation
|
|
|
|
Term
|
Definition
CH 7 Cholinoceptor-Activating & Cholinesterase-Inhibiting Drugs
Direct-Acting Nicotinic Agonist
Partial agonist at α4β2 nicotinic receptors
|
Nausea, insomnia, exacerbation of psychiatric illnesses
|
Smoking cessation
|
|
|
|
Term
|
Definition
CH 7 Cholinoceptor-Activating & Cholinesterase-Inhibiting Drugs
Short-Acting Cholinesterase Inhibitors
Reversibly bind to the active site preventing access of Ach; ↑ PNS activity and somatic neuromuscular transmission
|
Parasympathomimetic excess
|
Myasthenia gravis (diagnosis)
|
|
|
|
Term
|
Definition
CH 7 Cholinoceptor-Activating & Cholinesterase-Inhibiting Drugs
Intermediate-Acting Cholinesterase Inhibitors
Forms covalent bond with AChE, but hydrolyzed and released; like edrophonium but longer-acting
|
Parasympathetic excess
|
Myasthenia gravis, postoperative and neurogenic ileus and urinary retention
|
|
|
|
Term
|
Definition
CH 7 Cholinoceptor-Activating & Cholinesterase-Inhibiting Drugs
Intermediate-Acting Cholinesterase Inhibitors
Like neostigmine, but is a tertiary amine (more hydrophobic) and can cross the blood-brain barrier and enter CNS
|
Parasympathetic excess
|
Myasthenia gravis, glaucoma, Alzheimer’s disease
|
|
|
|
Term
|
Definition
CH 7 Cholinoceptor-Activating & Cholinesterase-Inhibiting Drugs
Long-Acting Cholinesterase Inhibitors
Like neostigmine, but released more slowly
|
Brow ache, uveitis (inflammation of interior of eye), blurred vision
|
Obsolete – was used in glaucoma
|
|
|
|
Term
|
Definition
CH 7 Cholinoceptor-Activating & Cholinesterase-Inhibiting Drugs
Long-Acting Cholinesterase Inhibitors
Irreversible cholinesterase
|
Low toxicity
|
Insecticide; used in low doses to treat lice (pediculosis), scabies
|
|
|
|
Term
|
Definition
CH 7 Cholinoceptor-Activating & Cholinesterase-Inhibiting Drugs
Long-Acting Cholinesterase Inhibitors
Irreversible cholinesterase
|
Extremely toxic
|
Nerve gas
|
|
|
|
Term
|
Definition
CH 7 Cholinoceptor-Activating & Cholinesterase-Inhibiting Drugs
Drugs to treat Alzheimer's
Anticholinesterase and other cholinomimetic actions
|
Hepatic toxicity
|
Alzheimer’s disease
|
|
|
|
Term
|
Definition
CH 7 Cholinoceptor-Activating & Cholinesterase-Inhibiting Drugs
Drugs to treat Alzheimer's
More selective acetylcholinesterase inhibitor
|
|
Alzheimer’s disease
|
|
|
|
Term
|
Definition
CH 7 Cholinoceptor-Activating & Cholinesterase-Inhibiting Drugs
Anticholinergic
Blocks fusion of vesicles with the surface membrane of nerve terminal preventing expulsion of ACh into synaptic cleft
|
Botulism - paralytic illness
|
Cosmetic procedures
|
|
|
|